​

Funding Round

Venture Round - EvolveImmune Therapeutics

Venture Round - EvolveImmune Therapeutics

Investment Firm

Overview

EvolveImmune Therapeutics develops a modular biotherapeutics platform specialized in immuno-oncology.

Announced Date

Nov 16, 2023

Funding Type

Series Unknown

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

5

Investor Name
Participant InvestorYonjin Venture
Participant InvestorTakeda Ventures
Participant InvestorSolasta Ventures
Participant InvestorPfizer
Participant InvestorElm Street Ventures

Round Details and Background

EvolveImmune Therapeutics raised $37398371 on 2023-11-16 in Venture Round

EvolveImmune Therapeutics develops a modular biotherapeutics platform specialized in immuno-oncology.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 08, 2020
Series A - EvolveImmune Therapeutics
5-17.5M
Nov 16, 2023
Venture Round - EvolveImmune Therapeutics
5-37.4M

Recent Activity

There is no recent news or activity for this profile.